Literature DB >> 3472355

Elective whole-lung irradiation in osteosarcoma treatment: appearance of bilateral breast cancer in two long-term survivors.

J C Ivins, W F Taylor, L E Wold.   

Abstract

The effect of "prophylactic" lung radiation in preventing pulmonary metastasis was studied in a subset of patients with osteosarcoma. Benefit was not noted. Thirteen of the irradiated patients in the treatment group were females; in 2 of the 13, bilateral breast cancer developed approximately 15 years later. Radiation administered to the breast of an adolescent female carries a considerable risk of causing breast cancer.

Entities:  

Mesh:

Year:  1987        PMID: 3472355     DOI: 10.1007/BF00367761

Source DB:  PubMed          Journal:  Skeletal Radiol        ISSN: 0364-2348            Impact factor:   2.199


  7 in total

1.  Second primary neoplasms in children.

Authors:  M Tefft; G F Vawter; A Mitus
Journal:  Am J Roentgenol Radium Ther Nucl Med       Date:  1968-08

2.  Radiation-induced breast cancer.

Authors:  N G Hildreth
Journal:  N Y State J Med       Date:  1984-12

Review 3.  The carcinogenicity of radiation therapy.

Authors:  D J Pizzarello; D F Roses; J Newall; R J Barish
Journal:  Surg Gynecol Obstet       Date:  1984-08

4.  Elective whole lung irradiation in the treatment of osteogenic sarcoma.

Authors:  G T Rab; J C Ivins; D S Childs; R E Cupps; D J Pritchard
Journal:  Cancer       Date:  1976-08       Impact factor: 6.860

5.  Breast carcinoma after cancer therapy in childhood.

Authors:  F P Li; J Corkery; G Vawter; W Fine; S E Sallan
Journal:  Cancer       Date:  1983-02-01       Impact factor: 6.860

6.  Radiation-induced breast cancer.

Authors:  N A Finnerty; A U Buzdar; G R Blumenschein
Journal:  Arch Intern Med       Date:  1984-06

7.  Breast cancer risk from low-dose exposures to ionizing radiation: results of parallel analysis of three exposed populations of women.

Authors:  C E Land; J D Boice; R E Shore; J E Norman; M Tokunaga
Journal:  J Natl Cancer Inst       Date:  1980-08       Impact factor: 13.506

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.